0001179110-18-002111.txt : 20180214 0001179110-18-002111.hdr.sgml : 20180214 20180214181108 ACCESSION NUMBER: 0001179110-18-002111 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180212 FILED AS OF DATE: 20180214 DATE AS OF CHANGE: 20180214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kaundinya Ganesh Venkataraman CENTRAL INDEX KEY: 0001294284 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50797 FILM NUMBER: 18614862 MAIL ADDRESS: STREET 1: C/O MOMENTA PHARMACEUTICALS, INC. STREET 2: 675 WEST KENDALL STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER NAME: FORMER CONFORMED NAME: Venkataraman Ganesh DATE OF NAME CHANGE: 20040618 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MOMENTA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001235010 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043561634 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 675 WEST KENDALL STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617 491-9700 MAIL ADDRESS: STREET 1: 675 WEST KENDALL STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 edgar.xml FORM 4 - X0306 4 2018-02-12 0 0001235010 MOMENTA PHARMACEUTICALS INC MNTA 0001294284 Kaundinya Ganesh Venkataraman C/O MOMENTA PHARMACEUTICALS, INC. 675 WEST KENDALL STREET CAMBRIDGE MA 02142 0 1 0 0 COO & CSO Common Stock 2018-02-12 4 M 0 10103 7.41 A 501031 D Common Stock 2018-02-12 4 S 0 341 16.20 D 500690 D Common Stock 2018-02-14 4 S 0 4645 15.16 D 496045 D Restricted Stock Units 2018-02-12 4 A 0 50000 0 D Common Stock 50000 50000 D Stock Option (Right to Buy) 7.41 2018-02-12 4 M 0 10103 7.41 A 2012-02-22 2018-02-22 Common Stock 10103 0 D This transaction was effected pursuant to a Rule 10b5-1 trading plan. Each Restricted Stock Unit represents a contingent right to receive one share of MNTA common stock. Subject to certain criteria, the restricted stock units will vest with respect to 50% of the shares on the first anniversary of the grant date, and the remaining 50% will vest on the second anniversary of the grant date. /s/ Marie T. Washburn as attorney in fact 2018-02-14